publication venue for
- Early rapid eye movement sleep behavior disorder predicts incident cognitive impairment in Parkinson?s disease across ages 2023
- Double blind, nonrandomized crossover study of active recharge biphasic deep brain stimulation for primary dystonia. 105328. 2023
- Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial. 105346. 2023
- A late-onset neurological disorder: Is progression inevitable? Expert Commentary. 105321. 2023
- A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons disease. 57-62. 2022
- Persons with Parkinson's disease show impaired interlimb coordination during backward walking. 25-29. 2021
- Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease: A Parkinson's foundation (PF) QII study. 115-122. 2021
- Variations in hospitalization rates across Parkinson's Foundation Centers of Excellence. 123-128. 2020
- Deep brain stimulation lead removal in Tourette syndrome. 89-93. 2020
- Motor outcomes and adverse effects of deep brain stimulation for dystonic tremor: A systematic review. 32-41. 2020
- The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. 37-43. 2020
- Gait characterization for patients with orthostatic tremor. 23-27. 2020
- Quality of life outcomes after deep brain stimulation in dystonia: A systematic review 2019
- Causes and outcomes of hospitalization in Lewy body dementia: A retrospective cohort study 2019
- Importance of the initial response to GPi deep brain stimulation in dystonia: A nine year quality of life study 2019
- A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia 2019
- Parkinson's disease motor subtype changes during 20 years of follow-up 2019
- Multimodal dopaminergic and free-water imaging in Parkinson's disease 2019
- Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials 2019
- A review of basal ganglia circuits and physiology: Application to deep brain stimulation 2019
- A Meta-Analysis: Parkinson’s disease and dual-task walking. . 62:28-35. 2019
- Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort. 3-7. 2018
- Deep Brain Stimulation associated gliosis: A post-mortem study 2018
- Pipeline to gene discovery - Analysing familial Parkinsonism in the Queensland Parkinson's Project 2018
- Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms. 2018
- Everyday functioning in Parkinson's disease: Evidence from the Revised-Observed Tasks of Daily Living (OTDL-R). 2018
- Predictors of clinically meaningful change in PDQ-39 in Parkinson's disease. 2018
- STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: A systematic review and meta-analysis. 2018
- Square Biphasic Pulse Deep Bain Stimulation for Essential Tremor: the Bip Tremor Study. 46:41-46. 2018
- Dystonia and Ataxia Progression in Spinocerebellar Ataxias. 45:75-80. 2017
- Measures of Impulsivity in Parkinson's Disease Decrease After DBS in the Setting of Stable Dopamine Therapy. 44:13-17. 2017
- Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's disease 2017
- Thalamic DBS With a Constant-Current Device in Essential Tremor: a Controlled Clinical Trial. 40:18-26. 2017
- Variable Frequency Stimulation of Subthalamic Nucleus in Parkinson's Disease: Rationale and Hypothesis. 39:27-30. 2017
- A Randomized Trial of Relamorelin for Constipation in Parkinson's Disease (Move-Pd): Trial Results and Lessons Learned. 37:101-105. 2017
- The Visual Kinetic Depth Effect Is Altered With Parkinson's Disease. 37:97-100. 2017
- Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease 2017
- Gender differences in Parkinson's disease depression. 36:93-97. 2017
- Motor subtype changes in early Parkinson's disease 2017
- SCA2 family presenting as typical Parkinson's disease: 34 year follow up. 40:69-72. 2017
- Emotion Modulation of the Startle Reflex in Essential Tremor: Blunted Reactivity to Unpleasant and Pleasant Pictures. 34:54-58. 2017
- Scheduled, Intermittent Stimulation of the Thalamus Reduces Tics in Tourette Syndrome. 29:35-41. 2016
- Conjugal parkinsonism - Clinical, pathology and genetic study. No evidence of person-to-person transmission. 31:87-90. 2016
- Conjugal parkinsonism is coincidental. 33:149-150. 2016
- DCTN1 p.K56R in progressive supranuclear palsy. 28:56-61. 2016
- LRRK2 variation and dementia with Lewy bodies. 31:98-103. 2016
- Association of Parkinson Disease Age of Onset With Drd2, Drd3 and Grin2B Polymorphisms. 22:102-105. 2016
- Depression and Clinical Progression in Spinocerebellar Ataxias. 22:87-92. 2016
- Incidence and Mortality Trends of Aspiration Pneumonia in Parkinson's Disease in the United States, 1979-2010. 21:1082-1086. 2015
- Discriminating Features of Gait Performance in Progressive Supranuclear Palsy. 21:888-893. 2015
- Orthostatic Tremor and Parkinsonism. 21:541. 2015-05-01
- Reply: the `Cognitions' Index of the Parkinson's Disease Questionnaire-39 Relates To Sleep Disturbances and Hallucinations. 21:351-352. 2015-03-01
- Response To Zolpidem in Oromandibular Dystonia: a Case Report. 21:154-155. 2015-02-01
- Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release. 21:1156-1163. 2015
- Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease. 21:1101-1104. 2015
- Novel LRRK2 mutations in Parkinsonism. 21:1119-1121. 2015
- Parkinson's disease, genetic variability and the Faroe Islands. 21:75-78. 2015
- Outcomes, Management, and Potential Mechanisms of Interleaving Deep Brain Stimulation Settings. 20:1434-1437. 2014-12-01
- Back To the Basics: Regular Exercise Matters in Parkinson's Disease: Results From the National Parkinson Foundation Qii Registry Study. 20:1221-1225. 2014-11-01
- Comparison of Voluntary and Reflex Cough Effectiveness in Parkinson's Disease. 20:1226-1230. 2014-11-01
- The Cognition and Emotional Well-Being Indices of the Parkinson's Disease Questionnaire-39: What Do They Really Measure?. 20:1236-1241. 2014-11-01
- A Novel Ftl Mutation Responsible for Neuroferritinopathy With Asymmetric Clinical Features and Brain Anomalies. 20:935-937. 2014-08-01
- Three Families With Perry Syndrome From Distinct Parts of the World. 20:884-888. 2014-08-01
- Attentional Resource Allocation and Swallowing Safety in Parkinson's Disease: a Dual Task Study. 20:439-443. 2014-04-01
- Consensus-Based Clinical Practice Recommendations for the Examination and Management of Falls in Patients With Parkinson's Disease. 20:360-369. 2014-04-01
- Mobility, Mood and Site of Care Impact Health Related Quality of Life in Parkinson's Disease. 20:274-279. 2014-03-01
- EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. 20:659-661. 2014
- Continuous In-Home Monitoring of Essential Tremor. 20:37-40. 2014-01-01
- Unilateral Thalamic Deep Brain Stimulation in Essential Tremor Demonstrates Long-Term Ipsilateral Effects. 19:1113-1117. 2013-12-01
- Caregiver Strain in Parkinson's Disease: National Parkinson Foundation Quality Initiative Study. 19:975-979. 2013-11-01
- High Rates and the Risk Factors for Emergency Room Visits and Hospitalization in Parkinson's Disease. 19:949-954. 2013-11-01
- The Effect of Tai Chi Exercise On Gait Initiation and Gait Performance in Persons With Parkinson's Disease. 19:955-960. 2013-11-01
- Effect of Lead Trajectory On the Response of Essential Head Tremor To Deep Brain Stimulation. 19:789-794. 2013-09-01
- Swallowing and Deep Brain Stimulation in Parkinson's Disease: a Systematic Review. 19:783-788. 2013-09-01
- Impact of Discontinuing Tremor Suppressing Medications Following Thalamic Deep Brain Stimulation. 19:171-175. 2013-02-01
- Self-Regulatory Practices of Drivers With Parkinson's Disease: Accuracy of Patient Reports. 19:176-180. 2013-02-01
- STX6 rs1411478 is not associated with increased risk of Parkinson's disease. 19:563-565. 2013
- Health Comorbidities and Cognition in 1948 Patients With Idiopathic Parkinson's Disease. 18:1073-1078. 2012-12-01
- Drivers With Parkinson's Disease: Who Participates in Research Studies?. 18:833-836. 2012-08-01
- Gpi and Stn Deep Brain Stimulation Can Suppress Dyskinesia in Parkinson's Disease. 18:814-818. 2012-08-01
- Deep Brain Stimulation Response in Pathologically Confirmed Cases of Multiple System Atrophy. 18:86-88. 2012-01-01
- Unilateral Deep Brain Stimulation Surgery in Parkinson'S Disease Improves Ipsilateral Symptoms Regardless of Laterality. 17:745-748. 2011-12-01
- Spinocerebellar Ataxia Type 10-a Review. 17:655-661. 2011-11-01
- It Is Time To Remove the `Benign' From the Essential Tremor Label. 17:516-520. 2011-08-01
- Hospitalization in Parkinson Disease: a Survey of National Parkinson Foundation Centers. 17:440-445. 2011-07-01
- Rescue Leads: a Salvage Technique for Selected Patients With a Suboptimal Response To Standard Dbs Therapy. 17:451-455. 2011-07-01
- Generic Versus Branded Pharmacotherapy in Parkinson's Disease: Does It Matter? a Review. 17:308-312. 2011-06-01
- Lateral Ventricle Volume Is Poor Predictor of Post Unilateral Dbs Motor Change for Parkinson's Disease. 17:343-347. 2011-06-01
- Botulinum Toxin Type a for the Treatment of Gastroparesis in Parkinson's Disease Patients. 17:285-287. 2011-05-01
- Lessons Learned From a Large Single Center Cohort of Patients Referred for Dbs Management. 17:236-239. 2011-05-01
- Management of the Hospitalized Patient With Parkinson's Disease: Current State of the Field and Need for Guidelines. 17:139-145. 2011-03-01
- The Trajectory of Apathy After Deep Brain Stimulation: From Pre-Surgery To 6 Months Post-Surgery in Parkinson's Disease. 17:182-188. 2011-03-01
- Measurement of Patient-Centered Outcomes in Parkinson's Disease: What Do Patients Really Want From Their Treatment?. 17:89-94. 2011-02-01
- The Distal Partial Trisomy 1Q Syndrome and Dystonic Tremor. 17:128-129. 2011-02-01
- Parkinsonism and Neurological Manifestations of Influenza Throughout the 20Th and 21St Centuries. 16:566-571. 2010-11-01
- Tests of Dorsolateral Frontal Function Correlate With Objective Stability in Early To Moderate Stage Parkinson's Disease. 16:590-594. 2010-11-01
- Piloting the Npf Data-Driven Quality Improvement Initiative. 16:517-521. 2010-09-01
- The impact of and the factors associated with drooling in Parkinson's disease. 475-7. 2010
- Factors Related To Extended Hospital Stays Following Deep Brain Stimulation for Parkinson's Disease. 16:324-328. 2010-06-01
- Identification and Management of Deep Brain Stimulation Intra- and Postoperative Urgencies and Emergencies. 16:153-162. 2010-03-01
- Converting the Updrs Part III To the Hoehn and Yahr Staging May Not Be Adequate for a Research Database. 16:150. 2010-02-01
- Istradefylline as Monotherapy for Parkinson Disease: Results of the 6002-Us-051 Trial. 16:16-20. 2010-01-01
- Effects of Home-Based Exercise On Postural Control and Sensory Organization in Individuals With Parkinson Disease. 15:742-745. 2009-12-01
- Side Onset Influences Motor Impairments in Parkinson Disease. 15:781-783. 2009-12-01
- The Current Prevalence and Factors Associated With Tardive Dyskinesia Among Filipino Schizophrenic Patients. 15:655-659. 2009-11-01
- Does Laterality of Motor Impairment Tell Us Something About Cognition in Parkinson Disease?. 15:315-317. 2009-05-01
- Greater Motor Improvement in Right Hemibody Parkinson's Patients After Dopaminergic Medications. 15:20-23. 2009
- Failed Dbs for Palliation of Visual Problems in a Case of Oculopalatal Tremor. 15:71-73. 2009-01-01
- A Case-Based Review of Troubleshooting Deep Brain Stimulator Issues in Movement and Neuropsychiatric Disorders. 14:532-538. 2008-11-01
- The Persistent Effects of Unilateral Pallidal and Subthalamic Deep Brain Stimulation On Force Control in Advanced Parkinson'S Patients. 14:481-494. 2008-08-01
- Neuropsychological Findings in Clinically Atypical Autopsy Confirmed Corticobasal Degeneration and Progressive Supranuclear Palsy. 14:376-378. 2008
- Efficacy and Safety of Purified Botulinum Toxin Type a (Dysport (R)) for the Treatment of Benign Essential Blepharospasm: a Randomized, Placebo-Controlled, Phase Ii Trial. 14:407-414. 2008-01-01
- Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases 2006
- Diabetes mellitus among parkinsonian patients treated chronically with clozapine.. 10. 2004
- Current practices of burst vs. spaced physical therapy applied to Parkinson's disease 2024
- Redistribution of joint moments and dynamic balance control during sit to stand task in persons with Parkinson's disease 2021
- Reply to letter to the editor, "A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia." 2020
- High Frequency Bilateral Globus Pallidus Interna Deep Brain Stimulation Can Improve Both Chorea and Dysarthria in Chorea-acanthocytosis 2019
- Comment On: ``Cancer in Parkinson's Disease{''} 2018
- Practical proactive and preventative Parkinson's disease strategies for management in the hospital setting. 105515. 2023
- Knowledge Gaps and Research Recommendations for Essential Tremor 2016
- Idiopathic Delayed-Onset Edema Surrounding Deep Brain Stimulation Leads: Insights From a Case Series and Systematic Literature Review 2016